Evidence map›Paper›PMID 39614618›Full record

ArticleCancer reports (Hoboken, N.J.)2024

Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Papillary Thyroid Carcinoma Variants.

Sakhr Alshwayyat, Haya Kamal, Owais Ghammaz, Tala Abdulsalam Alshwayyat, Mustafa Alshwayyat, Ramez M Odat, Hamdah Hanifa, Wafa Asha, Nesreen A Saadeh

Abstract read
In one paragraph

Article in Cancer reports (Hoboken, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sakhr AlshwayyatResearch Associate, King Hussein Cancer Center, Amman, Jordan.
Haya KamalFaculty of Medicine, Jordan University of Science & Technology, Irbid, Jordan.
Owais GhammazFaculty of Medicine, Jordan University of Science & Technology, Irbid, Jordan.
Tala Abdulsalam AlshwayyatFaculty of Medicine, Jordan University of Science & Technology, Irbid, Jordan.
Mustafa AlshwayyatFaculty of Medicine, Jordan University of Science & Technology, Irbid, Jordan.
Ramez M OdatFaculty of Medicine, Jordan University of Science & Technology, Irbid, Jordan.
Hamdah HanifaFaculty of Medicine, University of Kalamoon, Al-Nabk, Syria.ORCID 0000-0003-2970-7379
Wafa AshaDepartment of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
Nesreen A SaadehInternal Medicine Department, Jordan University of Science and Technology, Irbid, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHürthle cell (HCC) and columnar cell variants (CCV) are rare subtypes of thyroid cancer.

aimsThis study used machine learning (ML) to evaluate treatment effectiveness and develop prognostic models.

methodsChi-square tests, Kaplan-Meier curves, log-rank tests, and Cox regression were used. Five ML algorithms constructed prognostic models predicting 5-year survival, validated using the AUC of the ROC curve.

resultsAmong 3690 patients, 3180 had CCV and 510 had HCC. ML models showed metastasis, surgery + RT, and age were significant factors for HCC, while the N component of TNM, metastasis, and tumor size were significant for CCV.

conclusionThis study offers a comprehensive approach for treating and assessing prognosis in PTC variants. The ML models developed offer practical tools for personalized clinical decision-making.

Indexed as

Machine LearningThyroid Cancer, PapillaryThyroid NeoplasmsAdultAgedAlgorithmsClinical Decision-MakingFemaleHumansKaplan-Meier EstimateMaleMiddle AgedNeoplasm StagingPrognosisRetrospective StudiesROC Curveclinical decision‐makingmachine learningpapillary thyroid cancerprognosissurvival analysistreatment outcome

Identifiers

PMID39614618
PMCPMC11607134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.